Asthma is one of the biggest healthcare problems in the world
339M
62%
210M
Improving asthma control saves $4,700 per patient per year in the US
Our solution is built to stop asthma attacks before they happen
Digital Solution
Our app gathers clinical and environmental risk factors to determine the root cause of symptoms and poor asthma control.
Biomarker Data at Home
Patented sensor and device measures fractional exhaled nitric oxide (FeNO) in breath. FeNO is a clinically established biomarker of type 2 airway inflammation. We use it to biologically determine risk of attack, adherence, efficacy of medication, and exposure to environmental triggers.
myBiometry Prediction Engine
We aggregate all the guideline-based risk factors associated with uncontrolled symptoms and attacks to build personalized, predictive risk models for each patient. We’re building a proprietary dataset to train our machine learning models to stratify patients and identify those at risk.
Clinical Oversight
Our clinical team is available 24/7 to provide guideline-based education, coaching and support.
Actionable Insights
We put each result into context so patients can take action to lower their risk of attack and improve asthma control.
We leverage our own data to proactively engage patients before symptoms and attacks occur to deliver guideline-based coaching and education to improve self-management.
Asthma is just the beginning
Our technology has the potential to impact over 500 million patients.